Ann: IMUGENE ANNOUNCES A$80 MILLION INSTITUTIONAL PLACEMENT, page-14

IMUGENE ANNOUNCES A$80 MILLION INSTITUTIONAL PLACEMENT
_____________________________________________________________________________________
• Firm commitments received for an $80 million placement at $0.20 per share, representing a
11.1% discount to last close on 9 September 2022
• The company will have a pro-forma cash position of ~A$1751 million on completion of the
Placement, funding the company’s broad clinical pipeline of three platform technologies
• Shares issued under the placement represent a modest 6.8% of existing ordinary shares
• The Placement participants are two leading institutional investors with significant healthcare and
biotechnology experience
• Placement participants will receive 1 free option for every 2 shares received in the offer – the
options are unlisted with an exercise price of $0.33 and expiration of 31 March 2026

I don't like the fact that the inst investors are un named again. Why not just come out and tell us who you are?
Why the discount for $80m? They could have bought smaller chunks on market to get to that figure over a few weeks without diluting us and getting the discount. Plus the free options.